Week 12/1 Autism Pdd Ii Flashcards

0
Q

Current vaccination schedule in Quebec

A

 14 separate shots by 6 years of age
 Includes pneumonia, flu, rotavirus, chickenpox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Causes of autism?

A

Environmental Factors
Toxin hypotheses
– Gluten-based diet (cereal)
– Casein-based diet (milk)
– Toxic substances during pregnancy

Vaccinations
 Increase in number of vaccinations children receive  1900 – 1 – Small pox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Thimerosal in vaccines issue?

A

 Preservative in vaccines
 Removed from nearly all vaccines in 2001 (e.g., some flu vaccines, not given to children)

 Mercury
 Symptoms of autism are noticed right around the time
children get their vaccinations
 Reasonable biological explanation

Wakefield et al. 1998
 12 children
 Normal development followed by onset of behavioral difficulties and gastrointestinal problems
 For 8 children, onset was linked to MMR vaccine by parents or physician
 Note that the authors were careful to point out that this study did not prove a link between behavioral problems and vaccination
 Also noted that only a subset of autistic cases linked to vaccine!

After publication, MMR vaccine rates dropped
 In UK
 1996 – 92%
 2006 – 85% (compared to 94% for other vaccines)
 2006 incidence rates for measles and mumps were 13 and 37x times higher than in 1997, so paper had consequences!

No scientific evidence linking vaccines to autism!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

No scientific evidence linking vaccines to autism!

A

Subsequent research evidence
 12 epidemiological studies have found no link between the MMR (measles/mumps/rubella) vaccine and autism
 Largest: All children born in Denmark between January 1991 and December 1998 (N = 537, 303)
 6 studies have found no evidence of a link between thimerosal and autism
 3 studies have found no evidence that thimerosal is associated with more minor neurological difficulties

Most recently
 De Stefano et al. 2013, Journal of Pediatrics
 Examined association between level of immunological stimulation in first two years of life and development of autism
 Found no association
 Greater number of vaccines not associated with autism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Scientific inference

A

Null hypothesis: Assume no relationship
Using probability theory, determine how likely the observed relationship is if there is really no relationship
Could we expect to observe this association by chance?
We cannot quantify the likelihood of no relationship
We cannot “prove” the null hypothesis

U satisfying to parents/ppl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Issue is herd mentality of vaccine not working.

A

More cases, some ppl cannot take vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Update on Landet paper

A

 Lancet retracted the paper
 In January 2011, reported in the British Medical Journal that the data reported were in fact fraudulent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Genetic causes of autism

A

 Heritability
– Identical twin concordance of 60-90%
– Have one child with ASD, 1/15 of second births will have ASD
– Overall, evidence that autism is over 80% heritable
– Likely involves gene x gene interactions (5-100!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Brain Development in asd

A

 Evidence of abnormalities, but not clear if causal

Differences in structure
– Many areas (frontal lobe, cerebellum, medial temporal, limbic)

Differences in function
– Very high rates of epilepsy and seizures
– Decreased activation of emotion processing regions
– Structural and functional differences in the amygdala
– Decreased activation of “mirror neurons”
– Altered activation of facial recognition areas
– Children as young as 6 months show different brain activity when they see their mother versus a stranger
– Children with autism don’t show this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

“Biomedical” Treatments
For ASD

A

 Vitamins and diet
 Vitament supplements
 E.g., C, B6,magnesium
 Diet
 Gluten-free  Secretin (for ulcers)

Otherwise – Few studies, methodologically problematic
 No strong evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Secretin for ASD

A

 Used to treat peptic ulcers
 Three children with autism received it for unrelated conditions and improvement in symptoms of autism noted
 Several well-designed studies showing no effect
 Meta-analysis of 7 large studies concludes secretin is not effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

3 behavioural models to treat asd

A

Language and ommunciation foci

Social skills foci, eg. imitate others, demonstrate affection, reciprocate/initiale tantrum,
Tantrums, stim focIt

ABA
FLOORTIME
TEACH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Psychosocial Treatments for ASD

A

Common models Behavioral (ABA)
DIR / floor time
TEACCH
Common features
Early intervention
Many hours
Many staff
Structured
Intense family involvement!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ABA

A

 Discrete Trial Training, kid q’s
 Structured behavioral approach
 Therapist begins with a prompt that should elicit the desired skill/behavior (show me the 2! Show me the pretzel!)
 Prompt the behavior
 Reinforce the desired behavior
 Shaping, baby steps

Incidental training
 Reinforcing naturally occurring behaviors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

UCLA Early Autism Project
 Participants
Preschoolers with autism (mean age 32 months) Varying levels of MR and impairment

Design
Non-random assignment to conditions Ethical concerns
Parent protest
Children assigned to treatment condition unless there was an insufficient number of staff members (in which case assigned to control)

Children assigned to two groups
 19 children assigned to ABA therapy (40 hrs / week)
 19 children assigned to Special education + less intense ABA (10 hrs /week)
 Therapy lasted for at least two years
 Third group was added for analysis – children who had attended special education but not received any individual therapy
 Guard against referral bias,

A

No difference between treatment and control groups
on 19 out of 20 variables (e.g., age at diagnosis,
abnormal speech, self-stimulatory behavior)
 Control group 1 was slightly older but this was shown not to be related to outcomes
 In general, appears that the groups were comparable at intake

Outcomes (age 7)
47% of youths in intense ABA “recovered”
Completed first grade without support Promoted to second grade
IQ scores increased
2% of youths in control conditions (only one child)

Outcomes (Age 13)
 Follow up of the 9 children with the best outcomes
showed that they maintained their gains
 42% of children in intervention group were identified as having mild ID and placed in special ed classes
 11% classified as having profound ID

Gains were maintained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lovaas Method for ASD the ABA method

A

 A handful of additional studies have provided support for efficacy of this approach
 Currently identified as the only well-established treatment for autism

16
Q

Medication for ASD

Aside on experimental oxytocin with bartz…

A

 Currently used primarily to treat other psychiatric symptoms that may be present, rather than core features of autism
 SSRIsforanxiety/obsessive-compulsivebehavior
 Evidence is stronger for adults and adolescents with autism than with
 Stimulants for ADHD symptoms
 Some evidence suggesting improvement hyperactivity and inattention and lower levels of side effects than seen with other medications
 Response rate lower in children with autism than in children without autism
 Risperidone (atypical antipsychotic)
 One RCT shows improvement in self-injury, aggression,and agitation for children and adolescents with autism who received risperidone relative to placebo